Primavera Capital Group logo

Primavera Capital Group

Asia, Beijing, China, Beijing

Description

Primavera Capital Group is a prominent China-based private equity firm, established by Dr. Fred Hu, a former chairman of Goldman Sachs Greater China. The firm is recognized for its strategic investments across various sectors, primarily focusing on private equity and special situations opportunities. Primavera's investment philosophy emphasizes long-term value creation, leveraging its deep industry insights and extensive network to support the growth and transformation of its portfolio companies.

The firm's investment strategy is diversified yet concentrated on high-growth areas within the Chinese economy. Key sectors of interest include consumer and retail, technology, healthcare, and financial services. Primavera typically targets late-stage growth equity, pre-IPO investments, and buyouts, often taking significant stakes in leading companies with strong market positions and substantial growth potential. Their approach involves active partnership with management teams, providing strategic guidance and operational expertise to drive sustainable development.

Primavera Capital Group has demonstrated a robust fundraising capability, securing substantial capital commitments from global institutional investors. For instance, the firm successfully closed its fourth USD-denominated fund, Primavera Capital Fund IV, with over $4 billion in commitments in 2021. This followed the successful close of Primavera Capital Fund III, which secured $2.35 billion in 2018. These significant fund sizes underscore Primavera's capacity to deploy substantial capital into large-scale transactions.

Given their multi-billion dollar funds and focus on late-stage and buyout opportunities, Primavera's typical initial investment checks are substantial. While specific first check sizes can vary depending on the deal structure and the firm's role (lead or co-investor), their investments generally range from tens of millions to hundreds of millions of US dollars per transaction. The firm has a track record of investing in high-profile companies, including Alibaba's Cainiao, ByteDance, SenseTime, and Yum China, reflecting their preference for established market leaders or disruptive innovators requiring significant capital for expansion and strategic initiatives.

Investor Profile

Primavera Capital Group has backed more than 32 startups, with 2 new investments in the last 12 months alone. The firm has led 15 rounds, about 47% of its total and boasts 12 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Private Equity, Series D rounds (top funding stages).
  • Majority of deals are located in China, United States, Hong Kong.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Manufacturing.
  • Led 1 rounds in the past year.
  • Typical check size: $50M – $300M.

Stage Focus

  • Seed (22%)
  • Private Equity (16%)
  • Series D (13%)
  • Series B (13%)
  • Series A (13%)
  • Series C (9%)
  • Series Unknown (6%)
  • Series E (6%)
  • Series F (3%)

Country Focus

  • China (53%)
  • United States (22%)
  • Hong Kong (6%)
  • Singapore (6%)
  • United Kingdom (6%)
  • Indonesia (3%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Manufacturing
  • Health Care
  • Information Technology
  • Machine Learning
  • Software
  • Fintech
  • Medical
  • Internet
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Primavera Capital Group frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 2
Goldman Sachs
North America, New York, United States, New York
Co-Investments: 5
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 3
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 2
General Atlantic
North America, New York, United States, New York
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
Fidelity International
Europe, England, United Kingdom, London
Co-Investments: 2
CPE
Asia, Beijing, China, Beijing
Co-Investments: 2
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Boyu Capital
Asia, Beijing, China, Beijing
Co-Investments: 2

Which angels does Primavera Capital Group often collaborate with?

BS
North America, Massachusetts, United States, Needham
Shared Deals: 1
WM
North America, New York, United States, New York
Shared Deals: 1
CC
North America, California, United States, San Jose
Shared Deals: 1
MZ
North America, California, United States, Palo Alto
Shared Deals: 1
Adrian Cheng
Asia, Hong Kong
Shared Deals: 1
AH
North America, Texas, United States, Austin
Shared Deals: 1
YJ
North America, California, United States, Cupertino
Shared Deals: 1

What are some of recent deals done by Primavera Capital Group?

VAST is an artificial intelligence business that focuses on the study and production of general-purpose 3D big models.

3D TechnologyArtificial Intelligence (AI)
SeedSep 19, 2024
Adden Energy

Waltham, Massachusetts, United States

Adden Energy is a developer of stable, lithium-metal, solid-state batteries.

BatteryEnergy StorageGreenTech
Series ASep 3, 2024
Amount Raised: $14,999,974
LeyLine Technologies

Seattle, Washington, United States

The world's first Cybernetic Ecosystem for the creative industry.

GamingMarketplaceMedia and EntertainmentProject Management
SeedJul 1, 2024
OPTIX

Beijing, Beijing, China

OPTIX is a designer and manufacturer of AR waveguides and VR optics module.

ComputerElectronicsHardwareManufacturing
SeedMay 7, 2024
Amount Raised: $15,000,000
Corsair Pharma

Sunnyvale, California, United States

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Dietary SupplementsManufacturingTherapeutics
Series BSep 20, 2023
Amount Raised: $23,000,000
Blackpanda

Singapore, Central Region, Singapore

Blackpanda is a digital forensics and cyber incident response firm.

ComputerCyber SecurityInformation TechnologyInsurTechNetwork Security
Series AJan 18, 2023
Amount Raised: $15,000,000
Accession Therapeutics

Oxford, Oxfordshire, United Kingdom

Accession Therapeutics is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumor diversity.

BiopharmaBiotechnology
Series ANov 21, 2022
Amount Raised: $19,631,913
Enflame

Shanghai, Shanghai, China

Enflame is an artificial intelligence start-up developing cloud-based deep learning chips for AI training platforms.

Artificial Intelligence (AI)Machine LearningSemiconductorSoftware
Series CAug 10, 2022
PLANET TWELVE PRIVATE LIMITED

Singapore, Central Region, Singapore

Project Twelve is a gaming platform and game creator ecosystem.

BlockchainGaming
SeedJun 28, 2022
Amount Raised: $8,000,000
Dimension

San Francisco, California, United States

Dimension brings the waste management industry into the modern world.

Information TechnologyInternetMobile AppsSoftwareWaste Management
SeedMay 31, 2022
Amount Raised: $8,000,000